Your browser doesn't support javascript.
loading
Successful use of equine anti-thymocyte globulin (ATGAM) for fulminant myocarditis secondary to nivolumab therapy.
Tay, Rebecca Y; Blackley, Elizabeth; McLean, Catriona; Moore, Maggie; Bergin, Peter; Gill, Sanjeev; Haydon, Andrew.
Afiliação
  • Tay RY; Department of Medical Oncology, Alfred Health, Melbourne, Victoria 3004, Australia.
  • Blackley E; Department of Medical Oncology, Alfred Health, Melbourne, Victoria 3004, Australia.
  • McLean C; Department of Anatomical Pathology, Alfred Health, Melbourne, Victoria 3004, Australia.
  • Moore M; Monash University, Melbourne, Victoria 3800, Australia.
  • Bergin P; Department of Medical Oncology, Alfred Health, Melbourne, Victoria 3004, Australia.
  • Gill S; Heart Centre, Alfred Health, Melbourne, Victoria 3004, Australia.
  • Haydon A; Department of Medical Oncology, Alfred Health, Melbourne, Victoria 3004, Australia.
Br J Cancer ; 117(7): 921-924, 2017 Sep 26.
Article em En | MEDLINE | ID: mdl-28797029

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Protocolos de Quimioterapia Combinada Antineoplásica / Glioblastoma / Miocardite / Soro Antilinfocitário Limite: Animals / Female / Humans / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Protocolos de Quimioterapia Combinada Antineoplásica / Glioblastoma / Miocardite / Soro Antilinfocitário Limite: Animals / Female / Humans / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article